Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP898369.RAN08wcBWPsKHTuAXIaSDIP2feLXJFQ2gJCOr_btoc9_w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP898369.RAN08wcBWPsKHTuAXIaSDIP2feLXJFQ2gJCOr_btoc9_w130_assertion type Assertion NP898369.RAN08wcBWPsKHTuAXIaSDIP2feLXJFQ2gJCOr_btoc9_w130_head.
- NP898369.RAN08wcBWPsKHTuAXIaSDIP2feLXJFQ2gJCOr_btoc9_w130_assertion description "[While no significant difference in AHI1 expression was observed between newly diagnosed CML samples and non-CML controls; CML samples under imatinib therapy had levels significantly higher than both newly diagnosed samples and controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898369.RAN08wcBWPsKHTuAXIaSDIP2feLXJFQ2gJCOr_btoc9_w130_provenance.
- NP898369.RAN08wcBWPsKHTuAXIaSDIP2feLXJFQ2gJCOr_btoc9_w130_assertion evidence source_evidence_literature NP898369.RAN08wcBWPsKHTuAXIaSDIP2feLXJFQ2gJCOr_btoc9_w130_provenance.
- NP898369.RAN08wcBWPsKHTuAXIaSDIP2feLXJFQ2gJCOr_btoc9_w130_assertion SIO_000772 22183070 NP898369.RAN08wcBWPsKHTuAXIaSDIP2feLXJFQ2gJCOr_btoc9_w130_provenance.
- NP898369.RAN08wcBWPsKHTuAXIaSDIP2feLXJFQ2gJCOr_btoc9_w130_assertion wasDerivedFrom befree-20140225 NP898369.RAN08wcBWPsKHTuAXIaSDIP2feLXJFQ2gJCOr_btoc9_w130_provenance.
- NP898369.RAN08wcBWPsKHTuAXIaSDIP2feLXJFQ2gJCOr_btoc9_w130_assertion wasGeneratedBy ECO_0000203 NP898369.RAN08wcBWPsKHTuAXIaSDIP2feLXJFQ2gJCOr_btoc9_w130_provenance.